Theodore Iliopoulos
Geschäftsführer bei Polpharma SA
Profil
Theodore Iliopoulos is currently working as the Vice President-Operations at Polpharma SA since 2002.
Previously, he held the position of Principal at Bristol Myers Squibb Co. and Vice President-Operations at Patheon, Inc. Mr. Iliopoulos completed his undergraduate degree from the National & Kapodistrian University of Athens in 1970.
Aktive Positionen von Theodore Iliopoulos
| Unternehmen | Position | Beginn |
|---|---|---|
Polpharma SA
 Polpharma SA Pharmaceuticals: MajorHealth Technology Polpharma SA develops and manufactures generic drugs. It offers food for special medical purposes, on prescription, no prescription, and medical products. The company was founded in 1935 and is headquartered in Starogard Gdanski, Poland. | Geschäftsführer | 01.01.2002 |
Ehemalige bekannte Positionen von Theodore Iliopoulos
| Unternehmen | Position | Ende |
|---|---|---|
| PATHEON, INC. | Geschäftsführer | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Ausbildung von Theodore Iliopoulos
| National & Kapodistrian University of Athens | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Polpharma SA
Polpharma SA Pharmaceuticals: MajorHealth Technology Polpharma SA develops and manufactures generic drugs. It offers food for special medical purposes, on prescription, no prescription, and medical products. The company was founded in 1935 and is headquartered in Starogard Gdanski, Poland. | Health Technology |
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |